drugset / Trial / NCT00389025

Mast-Cell Stabilizing Effects of Olopatadine

NCT00389025

Phase 4 Completed 24 enrolled Alcon Research
RandomizedSingle-groupDouble-blindPrevention

Summary

To assess the effects of olopatadine of the release of mast cell histamine

Timeline

Start
2006-10
Primary completion
2007-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Olopatadine Other / unclassified

Indications